Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
55.96
-0.14 (-0.24%)
Nov 21, 2024, 3:09 PM EST - Market open
Corcept Therapeutics Employees
Corcept Therapeutics had 352 employees as of December 31, 2023. The number of employees increased by 53 or 17.73% compared to the previous year.
Employees
352
Change (1Y)
53
Growth (1Y)
17.73%
Revenue / Employee
$1,785,668
Profits / Employee
$399,111
Market Cap
5.86B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
RadNet | 8,441 |
Merit Medical Systems | 6,950 |
Waystar Holding | 1,400 |
Inspire Medical Systems | 1,011 |
Ionis Pharmaceuticals | 927 |
Lantheus Holdings | 834 |
Blueprint Medicines | 655 |
Cytokinetics | 423 |
CORT News
- 21 days ago - Corcept Therapeutics Incorporated (CORT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 21 days ago - Corcept Therapeutics Announces Third Quarter Financial Results, Positive Results From Phase 3 GRADIENT Trial in Patients With Cushing's Syndrome and Provides Corporate Update - Business Wire
- 4 weeks ago - Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call - Business Wire
- 5 weeks ago - Corcept: Key Announcements Coming Soon - Seeking Alpha
- 7 weeks ago - Corcept Therapeutics' Commercial Drug Korlym Sales Impress Despite Increased Competition, Analyst Boosts Price Forecast - Benzinga
- 2 months ago - 3 Small Biotech Stocks With The 'Big Mo' Right Now - Seeking Alpha
- 2 months ago - Corcept Therapeutics - Three Dynamic Catalysts To Reaccelerate Growth - Seeking Alpha
- 4 months ago - Corcept Therapeutics: Q2 Gains Overshadowed By Generic Competition And Speculative Pipeline - Seeking Alpha